NeoGenomics appoints Lynn Tetrault as Non-Executive Chair; VanOort to retire from board

NEOGENOMICS INC

Douglas VanOort resigned as Executive Chairman and Chair of the Board effective Oct 7, 2021; plans to retire from board by year-end.
Lynn Tetrault, former Lead Independent Director, appointed as Non-executive Chair effective Oct 7, 2021.
Tetrault to receive additional quarterly fee of $15,625 and a $50,000 equity grant for her role as Chair.
VanOort's resignation was not due to any dispute with the Company, management, or Board.
Tetrault brings over 25 years of healthcare experience, including EVP at AstraZeneca.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Douglas M. VanOort

Executive Chairman and Chairman of the Board

NEO · NEOGENOMICS INC

Effective: 2021-10-07
Successor: Lynn A. Tetrault
Filed: October 12, 2021, 7:59 PM ET

Douglas M. VanOort, the former Chief Executive Officer of NeoGenomics, Inc. (the “Company”) and currently the Company’s Executive Chairman and Chairman of the Board of Directors (the “Board”) of the Company, notified the Board of his voluntary decision to retire from the Company and that in connection with his retirement he was tendering his resignation as Executive Chairman and Chairman of the Board of the Company, effective October 7, 2021.

Appointed

Lynn A. Tetrault

non-executive Chair of the Board

NEO · NEOGENOMICS INC

Effective: 2021-10-07
Filed: October 12, 2021, 7:59 PM ET

appointed Lynn A. Tetrault, the Company’s Lead Independent Director, as the non-executive Chair of the Board, effective October 7, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Douglas M. VanOort resigned as Executive Chairman and Chairman of the Board at NEOGENOMICS INC.

Action: resigned
Role: Executive Chairman and Chairman of the Board

Exact text from the filing

Douglas M. VanOort, the former Chief Executive Officer of NeoGenomics, Inc. (the “Company”) and currently the Company’s Executive Chairman and Chairman of the Board of Directors (the “Board”) of the Company, notified the Board of his voluntary decision to retire from the Company and that in connection with his retirement he was tendering his resignation as Executive Chairman and Chairman of the Board of the Company, effective October 7, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Lynn A. Tetrault was appointed as non-executive Chair of the Board at NEOGENOMICS INC.

Action: appointed
Role: non-executive Chair of the Board

Exact text from the filing

appointed Lynn A. Tetrault, the Company’s Lead Independent Director, as the non-executive Chair of the Board, effective October 7, 2021.

View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR

accession 0001077183-21-000225

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.